Clinical Trial Update: Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers) [Phase 3]

View source ↗

Summary

Phase 3 safety study COMFORT Toddlers of the Viaskin Peanut Patch in peanut-allergic children ages 1 to 3 is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy

Drugs mentioned

• Viaskin Peanut Patch

Snippet

Sponsor: DBV Technologies | Conditions: Allergy, Peanut Allergy | Phase 3 | Status: RECRUITING